Chirurgische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
Ann Surg. 2010 Jun;251(6):1070-8. doi: 10.1097/SLA.0b013e3181d7789d.
We analyzed 3 previously identified cut-off values of lymph node ratios (0.17, 0.41, and 0.69) in a large population-based collective of patients with colorectal cancer for their prognostic value.
The lymph node ratio (LNR) (relation of tumor-infiltrated to total examined lymph nodes) has a high prognostic impact, but the relevant cut-off values are not determined.
Patients (N = 27,803) with a primary colorectal cancer diagnosed and operated in the Munich region between 1991 and 2006 were registered in the Munich Cancer Registry. Lymph node numbers and survival data were available for 17,309 patients with a mean follow-up of 5.9 years.
The mean number (+/-SD) of resected lymph nodes was 16.8 +/- 8.4. Twelve or more lymph nodes were resected in 76.8%. Estimated 5-year overall survival decreased significantly with increasing LNR: LNR = 0 in 71.4%, LNR 0.01 to 0.17 in 52.4%, LNR 0.18 to 0.41 in 33.3%, LNR 0.42 to 0.69 in 19.8%, and LNR > or = 0.70 in 8.3% (P < 0.001). Multivariable survival analyses identified separately both LNR and pN- category, as well as number of resected lymph nodes, patient's age, tumor location, pT-category, pM-status, R-status, tumor grade, and year of operation as independent prognostic factors.
: The 3 cut-off values of LNRs had strong independent prognostic value in a population-based collective of patients with colorectal cancer. The LNR should be routinely reported and included in the American Joint Committee on Cancer staging system. Nevertheless, the benefit of lymphadenectomy on survival is still unclear.
我们分析了在一个大型的基于人群的结直肠癌患者群体中,先前确定的三个淋巴结比值(LNR)截断值(0.17、0.41 和 0.69)的预后价值。
LNR(肿瘤浸润淋巴结与总检查淋巴结的比值)具有很高的预后影响,但相关的截断值尚未确定。
在 1991 年至 2006 年间,慕尼黑地区诊断和手术治疗的原发性结直肠癌患者被登记在慕尼黑癌症登记处。共有 17309 名患者的淋巴结数量和生存数据可用于分析,平均随访时间为 5.9 年。
切除的淋巴结的平均值(+/-SD)为 16.8 +/- 8.4。12 个或更多的淋巴结被切除的比例为 76.8%。随着 LNR 的增加,估计的 5 年总生存率显著下降:LNR=0 的患者占 71.4%,LNR 0.01 至 0.17 的患者占 52.4%,LNR 0.18 至 0.41 的患者占 33.3%,LNR 0.42 至 0.69 的患者占 19.8%,LNR≥0.70 的患者占 8.3%(P<0.001)。多变量生存分析分别确定了 LNR 和 pN 类别、切除的淋巴结数量、患者年龄、肿瘤位置、pT 类别、pM 状态、R 状态、肿瘤分级以及手术年份作为独立的预后因素。
LNR 的这 3 个截断值在基于人群的结直肠癌患者群体中具有很强的独立预后价值。LNR 应该被常规报告并纳入美国癌症联合委员会分期系统。然而,淋巴结切除术对生存的获益仍不清楚。